Bone regeneration in sheep model induced by strontium-containing mesoporous bioactive glasses
Javier Jiménez-Holguín1, Daniel Lozano2, Melchor Saiz-Pardo3
1Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain.
Strontium-containing bioactive mesoporous glasses (Sr-MBGs) significantly enhance bone regeneration in sheep models. Sr-MBGs promote osteogenesis and angiogenesis, offering a promising strategy for critical bone defect repair.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Materials Chemistry
Background:
- Local delivery of therapeutic ions from bioactive mesoporous glasses (MBGs) is a key strategy for bone defect regeneration.
- Strontium (Sr2+) is a promising therapeutic ion incorporated into MBGs for enhanced bone healing.
- Understanding the in vivo effects of Sr-containing MBGs is crucial for clinical translation.
Purpose of the Study:
- To investigate the bone regeneration potential of Sr-containing MBGs in a large animal model.
- To evaluate the impact of Sr2+ incorporation on the osteogenic and angiogenic properties of MBGs.
- To elucidate the mechanisms underlying Sr2+-enhanced bone formation.
Main Methods:
- MBGs with varying SrO content (0, 2.5, 5 mol%) were synthesized using the evaporation induced self-assembly (EISA) method.
- In vitro studies assessed apatite formation, preosteoblast (MC3T3-E1) viability, ALP activity, and gene expression (Runx2, ALP, VEGF).
- In vivo studies involved implanting MBGs and Sr-MBGs into cavitary bone defects in sheep, followed by histomorphometrical analysis and immunohistochemistry.
Main Results:
- Sr-MBGs exhibited similar apatite-forming ability to Sr-free MBGs in simulated body fluid (SBF).
- In vitro, Sr2+ enhanced MC3T3-E1 cell ALP activity and gene expression of Runx2, ALP, and VEGF, without affecting viability.
- HUVEC cell proliferation and VEGF expression increased with Sr2+ content.
- In vivo, Sr-MBGs significantly increased ossification area (20% vs 7%) and newly formed trabeculae thickness (30 μm vs 15 μm) compared to MBGs.
- Histological analysis indicated transient osteoclastogenesis inhibition and increased osteogenesis-angiogenesis.
Conclusions:
- Sr-MBGs demonstrate superior osteoregenerating potential compared to Sr-free MBGs in a large animal model.
- The enhanced bone formation is attributed to Sr2+-mediated osteogenesis and angiogenesis, potentially via osteoclastogenesis inhibition.
- Sr-containing MBGs represent a promising biomaterial for the treatment of critical bone defects.
More Related Videos
08:41Calvarial Model of Bone Augmentation in Rabbit for Assessment of Bone Growth and Neovascularization in Bone Substitution Materials
Published on: August 13, 2019
05:10Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model
Published on: February 7, 2025
Related Concept Videos
Bone Remodeling
Growth of Cartilage and Bone Tissue
Osteoclasts in Bone Remodeling
The Bone Matrix
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Bone Formation by Endochondral Ossification
